Auditory Stimulation for Insomnia and Depression
NCT: NCT07553364 · NOT_YET_RECRUITING
Brief Summary
The goal of this clinical trial is to determine if alpha phase-locked auditory stimulation can improve sleep in people with insomnia and depression. The main goals of the pilot study are the following: Determine whether alpha phase-locked auditory stimulation (active stimulation) improves objective and subjective sleep in individuals with insomnia and depression. The study team hypothesizes that active auditory stimulation will reduce objective and subjective sleep onset latency (SL) and wake after sleep onset (WASO) compared to a sham stimulation. Participants will: * Wear Elemind Neuromod headband nightly for 4 weeks (1 week baseline, 1 week active/sham stimulation, 1 week washout, and 1 week opposite condition - active/sham stimulation) * Wear actigraphy watch for duration of the study * Complete questionnaires regarding their sleep, mood, and satisfaction with the device
Frequently Asked Questions
What is Auditory Stimulation for Insomnia and Depression?
Auditory Stimulation for Insomnia and Depression is a clinical trial registered under NCT07553364. Current status: NOT_YET_RECRUITING.
What is the status of NCT07553364?
The current status of NCT07553364 (Auditory Stimulation for Insomnia and Depression) is: NOT_YET_RECRUITING.
When did Auditory Stimulation for Insomnia and Depression start?
Auditory Stimulation for Insomnia and Depression started on 2026-06-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.